5. Chronic Urticaria
Vitamin D ↓ has been demonstrated in CU, and vitamin D replacement has been
shown to help symptoms of CU.
Predominantly in allergy and immunology literature
International studies, where reimbursement may differ from US
Can vitamin D supplementation ↓urticaria symptoms regardless of vitamin D
level?
Conclusion: “Add‐on therapy with high‐dose vitamin D3 (4000 IU/day) could be
considered a safe and potentially beneficial immunomodulator in patients with
chronic urticaria.”
6. Vitamin D – Chronic Urticaria
Mechanisms of benefit of Vitamin D in Urticaria?
• Anti‐inflammatory properties of vitamin D.
• Vitamin D shown to contribute to the conversion of CD4 + T cells to T regulatory cells,
which may help with suppression of pro‐inflammatory mechanisms.
• Inhibits production of numerous cytokines, such IL‐1, L‐6, IL‐12, IL‐23, and others.
• Enhances ICAM expression in mast cells →Modulate proliferation, apoptosis, cytokine
production of mast cells.
7. Conclusion?
• I check the level and replace as noted earlier, however….
•If the levels are normal, I still recommend taking 3000‐4000 IU/day of vitamin D 3
8. Atopic dermatitis
Literature consistently shows low 25 (OH)D levels associated with
increased Fitzpatrick skin type
Mechanism of benefit of vitamin D in atopic dermatitis?
•Supplementation may increase antimicrobial peptides
•Cathelicidin, LL‐37, β‐defensin
• Vitamin D‐mediated activation of toll‐like receptors
• Anti‐inflammatory
9. Conclusion? When to consider vitamin D status in AD?
•Patient who is Skin Type IV or darker, regardless of age or severity of AD
•Adult patient with severe AD, regardless of phototype
•Replace to normalcy, then continue with maintenance dosing.
10. Vitiligo
Pediatric patients:
• Recent study demonstrating benefit with vitamin D supplementation along with
topical tacrolimus treatment vs topical tacrolimus treatment alone*
• 1500 IU/day given if level < 20 and 3000 IU/day given if level < 10
•Re‐pigmentation more effective with combination treatment
Adults:
•No clear evidence of association or benefit with supplementation at this time.
KaragüzelG, Sakarya NP, Bahadır S, Yaman S, ÖktenA. Vitamin D status and the effects of oral vitamin D treatment in children with
vitiligo: A prospective study. Clin Nutr ESPEN. 2016 Oct;15:28‐31.
11. Possible mechanism of how vitamin D may affect vitiligo:
• Immunomodulatory effects as described
• Vit D Receptor gene polymorphisms and relationship to autoimmunity. High doses
of D3 in patients with autoimmune disorders may compensate for resistance to its
effects based on gene polymorphisms
• Possible anti‐oxidant effect
13. Hidradenitis Suppurativa
• 500 mg BID
Acne
• 500 mg QD‐BID
• Varies depending on age and motivation of patient
•study exploring P. acnes induced inflammatory mediators and the effect of certain
herbs on these mediators→
• P. acnes induced reactive oxygen species and pro‐inflammatory cytokines IL‐8
and TNF‐alpha ↓by curcuma longa*
14. Numerous studies showing following benefits :
•Alzheimer’s Disease and neuro‐protection
• Antibacterial, antiviral, anti‐larval, antifungal
• Cutaneous disease and skin health
• Anti‐neoplastic
• Anti‐inflammatory
•Cardiovascular health and cardio‐protection
• Anti‐oxidant
• Wound healing
• Diabetes control
• Numerous others…
15. Resistant” comedones, particularly if very itchy
• Think Malassezia
• Fluconazole 100‐200 mg QD for 2‐4 weeks, or longer as needed
Consider Malassezia as well for:
• Extremely pruritic scalps with scattered non‐specific tiny papules
• Itchy scalp, chest and back
Dry lips from Isotretinoin
Make their own balm with 1% HC ointment in a lip pot container with
aquaphor
16. •Smoking cessation
• Weight loss, if patient is overweight or obese
• Turmeric at a dose of 500 mg BID
•Consider vitamin D and probiotics, depending on patient’s willingness,
financial constraints
•Consider bleach baths as inexpensive antisepsis. Alternatively, BPO wash
•If severe, TNF‐alpha inhibitors!
17.
18.
19.
20.
21. What is your diagnosis?
A.Scabies
B.Prurigo Nodularis
C.Dermatitis Herpetiformis
D.Bullous Pemphigoid
E.Lymphoma
22. DIF: Linear deposition of IgG along BMZ
I1:640 BMZ titer on monkey esophagus with
epidermal pattern on salt-split skin
Elevated BP180 (90) and BP230 (90)
Final diagnosis: Bullous pemphigoid (pemphigoid nodularis)
23.
24.
25.
26. What is the most likely diagnosis?
A.Lichen planus
B. Lichenoid drug reaction
C. Secondary syphilis
D. Keratosis lichenoides chronica
E. Pityriasis lichenoides
27. This disorder may be associated with which of the following
conditions:
A. Hyperthyroidism
B. Lymphoproliferative disorders
C. Hepatitis C infection
D. Inflammatory bowel disease
E. Connective tissue disease
28.
29.
30.
31. What is the most likely diagnosis?
A) Sarcoidosis
B) Disseminated cryptococosis
C) Lepromatous leprosy
D) Granulomatous mycosis fungoides
E) Granulomatous secondary syphilis
32. Which special stain would be useful to confirm the diagnosis?
A) Ziehl-Neelsen stain
B) Fite stain
C) PAS stain
D) GMS stain
E) IHC using Anti – Treponema antibody
33.
34.
35. • Superficial and deep
lymphocytic infiltrate
•Perivascular and periadnexal
36.
37. The pathologist says it looks like lupus erythematosus. What is
your next step?
A. Ask about work and hobbies
B. Ask about exposure to ticks
C. Check renal function
D. Check CPK/aldolase
E. Ask about rash in others at home
38.
39. Besides equestrians, what other patient population might
have a similar problem? Patients with
A.Chronic migraines
B.Chronic low back pain
C.Diabetes
D.Inflammatory bowel disease
E.Metastatic melanoma on nivolumab
40.
41.
42.
43. What is the diagnosis?
A. Infection
B. Sweet’s syndrome
C. Pyoderma gangrenosum
D. Acute halogenoderma
E. Still’s disease
48. *Neclear erthroid 2-related factor 2- antioxidant response
element (Nrf2-Are): critical pathway in protecting cells from
oxidative stress
49. • Afamelanotide
• A synthetic analog of naturally occurring alpha- MSH
• Best outcome in darker racial ethnic group
• Max. improv. Combination with NBUVB
•Prostaglandin f2α analogues:
Latanoprost
Bimatoprost
50. • Nrf2 activators:
• Dimethyl fumarate ( Tecfidera): protected normal and
vitiligoo melanocytes against monobenzone induced
toxicity.
• JAK1/JAK2 inhibitir:
• Ruxolitinib 1.5% cream BD
• 20 week study → 23% improvement in VASI score.